Page last updated: 2024-08-25

bexarotene and Pituitary Neoplasms

bexarotene has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Du, G; Lv, T; Ren, S; Sun, L; Wang, J; Yu, H	1

Other Studies

1 other study(ies) available for bexarotene and Pituitary Neoplasms

Article	Year
Bexarotene combined with lapatinib for the treatment of Cushing's disease: evidence based on drug repositioning and experimental confirmation. Signal transduction and targeted therapy, 2020, 08-29, Volume: 5, Issue:1 Topics: Adrenocorticotropic Hormone; Animals; Bexarotene; Drug Combinations; Drug Repositioning; Humans; Lapatinib; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Protein Interaction Maps; Retinoid X Receptor alpha	2020

Article

Year

Bexarotene combined with lapatinib for the treatment of Cushing's disease: evidence based on drug repositioning and experimental confirmation.

Signal transduction and targeted therapy, 2020, 08-29, Volume: 5, Issue:1

Topics: Adrenocorticotropic Hormone; Animals; Bexarotene; Drug Combinations; Drug Repositioning; Humans; Lapatinib; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Protein Interaction Maps; Retinoid X Receptor alpha

2020